Activity of trovafloxacin in combination with other drugs for treatment of acute murine toxoplasmosis.

Current therapy for toxoplasmosis with a synergistic combination of pyrimethamine plus sulfadiazine or pyrimethamine plus clindamycin is not always efficacious and is frequently discontinued due to intolerable toxic effects in immunocompromised individuals, particularly those with AIDS. Trovafloxaci...

Descrición completa

Detalles Bibliográficos

Publicado en:	Antimicrob Agents Chemother
Principais autores:	Khan, A A, Slifer, T, Araujo, F G, Polzer, R J, Remington, J S
Formato:	Artigo
Idioma:	Inglês
Publicado:	American Society for Microbiology (ASM) 1997
Assuntos:	Research Article
Acceso en liña:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163821/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9145840/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.41.5.893
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!